Ligand id: 7106

Name: acamprosate

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: acamprosate

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 95.34
Molecular weight 181.04
XLogP -0.63
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

1. De Witte P, Littleton J, Parot P, Koob G. (2005)
Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.
CNS Drugs, 19 (6): 517-37. [PMID:15963001]
2. Erickson CA, Mullett JE, McDougle CJ. (2010)
Brief report: acamprosate in fragile X syndrome.
J Autism Dev Disord, 40 (11): 1412-6. [PMID:20213249]
3. Erickson CA, Wink LK, Ray B, Early MC, Stiegelmeyer E, Mathieu-Frasier L, Patrick V, Lahiri DK, McDougle CJ. (2013)
Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.
Psychopharmacology (Berl.), 228 (1): 75-84. [PMID:23436129]